Equity · Healthcare
OTLK
NASDAQOutlook Therapeutics (OTLK)
The line runs 0.6727 USD on 17 August through 0.4132 USD on 13 November, on a scale from 0.4 to 0.8. Days the market did not trade hold the previous close, flat.
- Market cap
- 100.6M USD
- Revenue, year to Sep 2025
- 1.4M USD
- EPS, diluted, year to Sep 2025
- −1.79 USD
- Avg volume
- 80.6K
- Mentions, 30 days
- 1
as of Nov 13, 2026
Have Outlook Therapeutics (OTLK) insiders bought or sold shares recently?
OTLK's newest Form 4 filing is dated 14 August 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Aug 2026 | KENYON LAWRENCE AChief Financial Officer | Buy | 101,010 | — |
| 14 Aug 2026 | Jahr Robert CharlesChief Executive Officer | Buy | 151,515 | — |
| 12 Aug 2026 | Sukhtian Ghiath M.Director | Buy | 2,525,252 | 2.5M USD |
| 29 Jul 2026 | Sukhtian Faisal GhiathDirector | Buy | 95,398 | 100K USD |
| 02 Jun 2026 | Haddadin Yezan MuntherDirector | Buy | 29,000 | 24K USD |
| 28 May 2026 | Sukhtian Ghiath M.Director | Buy | 8,539,709 | 5.0M USD |
| 27 May 2026 | Sukhtian Faisal GhiathDirector | Buy | 122,174 | 50K USD |
| 26 May 2026 | Haddadin Yezan MuntherDirector | Buy | 34,000 | 15K USD |
| 26 May 2026 | THURMAN RANDY HDirector | Buy | 5,000 | 2K USD |
| 26 May 2026 | HILZINGER KURT JDirector | Buy | 400,000 | 177K USD |
| Bought | 10 open-market purchases | 12,003,058 | $7.87M |
Which funds hold Outlook Therapeutics (OTLK)?
2 of the 45 institutional funds we track reported a Outlook Therapeutics position for the quarter ended 30 Sep 2026 — a combined 5.2M USD; the latest of those filings landed 13 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Marshall Wace | Added | 8,023,703 | 4.6M USD | +303.7% |
| Renaissance Technologies | New position | 1,120,688 | 643K USD |
What has been filed or recorded for Outlook Therapeutics (OTLK)?
The filings we hold for Outlook Therapeutics, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 3,339 shares | 2K USD notional · 0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,379 shares | 772 USD notional · 0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 165,010 shares | 97K USD notional · 0.068% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 93,253 shares | 53K USD notional · 0.038% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 130,120 shares | 78K USD notional · 0.053% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 97,190 shares | 57K USD notional · 0.040% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 20,195 shares | 12K USD notional · 0.008% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 138,353 shares | 79K USD notional · 0.057% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.15 USD | |
| 30 Jun 2026 | Financials | Total assets | 26.2M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −10.4M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.05 USD | |
| 31 Dec 2025 | Quarterly earnings | Q1 2026 reported | EPS −0.38 USD | |
| 30 Sep 2025 | Annual report | FY 2025 reported | EPS −1.79 USD | |
| 30 Sep 2025 | Financials | Revenue | 1.4M USD | fiscal year |
| 30 Sep 2025 | Financials | Net income | −62.4M USD | fiscal year |
| 30 Sep 2025 | Financials | Diluted EPS | −1.79 USD | fiscal year |
| 30 Jun 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.55 USD | |
| 31 Mar 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.50 USD | |
| 31 Dec 2024 | Quarterly earnings | Q1 2025 reported | EPS 0.72 USD | |
| 30 Sep 2024 | Annual report | FY 2024 reported | EPS −4.06 USD |
What is Reddit saying about Outlook Therapeutics (OTLK)?
Reddit mentioned OTLK 1 times in the 30 days to 14 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 0% bearish and 100% neither. Reddit data updated 14 November 2026.
30-day window, Method
How do Reddit mentions of Outlook Therapeutics (OTLK) compare with its price?
Share ↗
Which subreddits are talking about Outlook Therapeutics (OTLK)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.01 |
What do people ask about Outlook Therapeutics (OTLK)?
What did Outlook Therapeutics shares close at?0.4132
Outlook Therapeutics closed at 0.4132 USD on 13 Nov 2026, down 6.13% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Outlook Therapeutics’ market cap?100.6M
Outlook Therapeutics is worth 100.6M USD by market value as of 13 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Outlook Therapeutics’ revenue?1.4M
Outlook Therapeutics reported revenue of 1.4M USD for the year ended 30 Sep 2025, as filed with the SEC. See Filings
Have Outlook Therapeutics insiders bought or sold shares recently?
No Outlook Therapeutics insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 14 Aug 2026 (SEC Form 4). See Insiders
Which funds own Outlook Therapeutics?2 of 45
2 of the 45 funds we track reported a Outlook Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Marshall Wace and Renaissance Technologies. See Funds
When did Outlook Therapeutics last report earnings?−0.15
Outlook Therapeutics last reported earnings on 30 Jun 2026 for Q3 2026, with EPS of −0.15 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Outlook Therapeutics?0 mentions
Outlook Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 0% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings